Results 11 to 20 of about 1,912,527 (212)

Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year followup in the West of Scotland Cancer Network [PDF]

open access: yes, 2011
Clinically and biologically, nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) has much more in common with germinal-center derived B-cell non-Hodgkin lymphoma (NHL) than with classical Hodgkin lymphoma (cHL).
Diehl V   +8 more
core   +1 more source

Survival Outcomes and Prognostic Factors in Salivary Gland Cancers Treated by Surgery and Adjuvant Radiotherapy

open access: yesNamık Kemal Tıp Dergisi, 2021
Aim:To evaluate the variables affecting prognostic factors in patients with salivary gland cancer who have received surgery followed by radiotherapy (RT).Materials and Methods:Fifty-three patients with major and minor salivary gland cancer were treated ...
Mürsel DÜZOVA, Tahir Sedat TURKAN
doaj   +1 more source

Circulating cell death products predict clinical outcome of colorectal cancer patients. [PDF]

open access: yes, 2009
BackgroundTumor cell death generates products that can be measured in the circulation of cancer patients. CK18-Asp396 (M30 antigen) is a caspase-degraded product of cytokeratin 18 (CK18), produced by apoptotic epithelial cells, and is elevated in breast ...
Hommes, Daan W   +3 more
core   +2 more sources

Clinicopathological Characteristics of Triple-negative Breast Cancers in the Northeast Region of Turkey

open access: yesBalkan Medical Journal, 2014
Background: Triple-negative (TN) breast cancer is a subtype of breast cancer characterised by a loss of estrogen receptor (ER), progesterone receptor (PR) expression, and the absence of human epidermal growth factor (HER2) overexpression.
Bülent Yıldız   +5 more
doaj   +1 more source

A phase II study of capecitabine and oxalplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract [PDF]

open access: yes, 2016
Background: Advanced biliary tract carcinomas are associated with a poor prognosis, and palliative chemotherapy has only modest benefit. This multi-centre phase II study was conducted to determine the efficacy of capecitabine in combination with ...
E. Soulis   +10 more
core   +1 more source

Prognostic Value of Lymph Node Density in Patients With T3 and T4 Pyriform Sinus Carcinoma

open access: yesTechnology in Cancer Research & Treatment, 2020
Background/Aim: Lymph node density is a parameter used to more accurately predict tumor recurrence and patient survival. However, its association with surgical outcome in pyriform sinus carcinoma remains unclear.
Lifeng Jia PhD   +3 more
doaj   +1 more source

Comprehensive Analysis of the Expression Characteristics of the Enhancer of the Zeste Homolog 2 Gene in Pan-Cancer

open access: yesFrontiers in Genetics, 2021
Although more and more studies have shown that EZH2 was closely related to human cancer, no pan-cancer analysis is available. Therefore, we summarized and analyzed the potential carcinogenic effect of EZH2 for the first time based on TCGA (cancer genome ...
Yuanyuan Kang, Ying Zhang, Yan Sun
doaj   +1 more source

Prognostic Factors Affecting Disease-Free Survival and Overall Survival in T4 Colon Cancer [PDF]

open access: yesAnnals of Coloproctology, 2021
Purpose It is known that as the T stage of a carcinoma progresses, the prognosis becomes poorer. However, there are few studies about factors that affect the prognosis of T4 advanced colon cancer.
Taeyeong Eom   +8 more
doaj   +1 more source

Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment. [PDF]

open access: yes, 2011
BACKGROUND: Surgery is an important part of the management of oral cavity cancer with regard to both the removal of the primary tumour and removal of lymph nodes in the neck. Surgery is less frequently used in oropharyngeal cancer.
Bessell, A   +9 more
core   +3 more sources

Can contrast-enhanced MR imaging predict survival in breast cancer? [PDF]

open access: yes, 2003
PURPOSE: To investigate the value of pre-operative contrast-enhanced MR imaging (CE-MRI) in predicting the disease-free and overall survival in breast cancer.
Aspelin, Peter   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy